CARM
Price
$0.39
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
16.21M
VCYT
Price
$25.25
Change
+$1.66 (+7.04%)
Updated
Jul 25 closing price
Capitalization
1.66B
11 days until earnings call
Interact to see
Advertisement

CARM vs VCYT

Header iconCARM vs VCYT Comparison
Open Charts CARM vs VCYTBanner chart's image
Carisma Therapeutics
Price$0.39
Change-$0.00 (-0.00%)
Volume$539.73K
Capitalization16.21M
Veracyte
Price$25.25
Change+$1.66 (+7.04%)
Volume$5.36M
Capitalization1.66B
CARM vs VCYT Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. VCYT commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Hold and VCYT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CARM: $0.39 vs. VCYT: $25.25)
Brand notoriety: CARM and VCYT are both not notable
CARM represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CARM: 3% vs. VCYT: 527%
Market capitalization -- CARM: $16.21M vs. VCYT: $1.66B
CARM [@Biotechnology] is valued at $16.21M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CARM and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 3 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • CARM’s TA Score: 3 bullish, 4 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than CARM.

Price Growth

CARM (@Biotechnology) experienced а -1.07% price change this week, while VCYT (@Medical Specialties) price change was +7.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was -2.20%.

Reported Earning Dates

CARM is expected to report earnings on May 13, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than CARM($16.2M). CARM YTD gains are higher at: -7.354 vs. VCYT (-36.237). VCYT (-49.41M) and CARM (-49.68M) have comparable annual earnings (EBITDA) . VCYT has more cash in the bank: 216M vs. CARM (7.74M). CARM has less debt than VCYT: CARM (2.33M) vs VCYT (12.6M). VCYT has higher revenues than CARM: VCYT (361M) vs CARM (20M).
CARMVCYTCARM / VCYT
Capitalization16.2M1.66B1%
EBITDA-49.68M-49.41M101%
Gain YTD-7.354-36.23720%
P/E RatioN/AN/A-
Revenue20M361M6%
Total Cash7.74M216M4%
Total Debt2.33M12.6M18%
FUNDAMENTALS RATINGS
CARM vs VCYT: Fundamental Ratings
CARM
VCYT
OUTLOOK RATING
1..100
6374
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10086
PRICE GROWTH RATING
1..100
5365
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (77) in the Biotechnology industry is in the same range as CARM (93) in the null industry. This means that VCYT’s stock grew similarly to CARM’s over the last 12 months.

VCYT's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that VCYT’s stock grew similarly to CARM’s over the last 12 months.

VCYT's SMR Rating (86) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that VCYT’s stock grew similarly to CARM’s over the last 12 months.

CARM's Price Growth Rating (53) in the null industry is in the same range as VCYT (65) in the Biotechnology industry. This means that CARM’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's P/E Growth Rating (93) in the Biotechnology industry is in the same range as CARM (100) in the null industry. This means that VCYT’s stock grew similarly to CARM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CARMVCYT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCMVX21.040.14
+0.67%
Monongahela All Cap Value
FRMPX27.34N/A
N/A
Nuveen Small Cap Growth Opp A
OGLNX98.43N/A
N/A
Invesco Global R
PIIQX13.29N/A
N/A
Principal International Equity Index R5
LAVVX16.50N/A
N/A
Lord Abbett Fundamental Equity R6

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-1.62%
EVGN - CARM
59%
Loosely correlated
-2.96%
INSM - CARM
44%
Loosely correlated
+0.42%
PMVP - CARM
33%
Poorly correlated
-2.08%
VCYT - CARM
31%
Poorly correlated
+7.04%
ADPT - CARM
30%
Poorly correlated
+0.84%
More